Scientists are trialling semaglutide marketed as Ozempic and Wegovy on 3,680 patients with early Alzheimer's with results reported next year.
Semaglutide reduces inflammation, which is common in many conditions such as Alzheimer's and Parkinson's disease as well as Type 2 diabetes, heart disease and lupus.
One US study of more than one million Type 2 diabetes patients found those on semaglutide had up to a 70% reduced risk of being diagnosed with Alzheimer's within the next three years.
This story is from the December 27, 2024 edition of Daily Express.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 27, 2024 edition of Daily Express.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
I REMEMBER THINKING "WHERE ARE MY LEGS?'
Double amputee Martine Wright was the worst injured female survivor of the 7/7 London terror atrocities. Ahead of this year's 20th anniversary, she reveals why she chose happiness over hate through campaigning, motherhood and building a sense of purpose
How another UK native could help give a boost to under-threat red squirrels
TORIES are urging ministers to save our red squirrels by reintroducing pine martens and making their grey cousins infertile.
Mortgage approvals are hit by low consumer confidence
THE number of mortgages approved by the UK banking sector fell faster than expected in November.
MO IS BACK FOR MORE
Red-hot Salah out to haunt United again as Arne's top boys smell blood at Anfield
HOWE TO DO IT
Eddie has found right mix of exciting attack and rock-solid defence
Blame City slump on me...not my_players
GUARDIOLA IS BAFFLED BY ALARMING DECLINE
Kasper's career advice pays off for Jakub
LOANS HELP GOALKEEPER
SKY THE LIMIT
How Littler has taken pub game to the stratosphere
Jamie racks up big score
GEORGE'S 300 FOR SARRIES
FESTIVAL JUKEBOX ISSUE
Pauling ponders over his chaser's Cheltenham trip
